Patents Assigned to Arakis Ltd.
  • Treatment of inflammatory disorders
    Patent number: 7034028
    Abstract: A method of treating an inflammatory disease or an autoimmune disease in a subject, comprises the administration of mefloquine.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: April 25, 2006
    Assignee: Arakis Ltd.
    Inventors: Benjamin Mark Skead, Robin Mark Bannister, Alan Rothaul
  • Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
    Patent number: 6677326
    Abstract: The subject invention concerns a unit dose formulation comprising less than 2.5 mg of prednisolone or an equivalent, equipotent amount of another corticosteroid. One embodiment of a method of the invention concerns once daily administration of the unit dose formulation between midnight and 6 a.m. for the treatment of rheumatoid arthritis.
    Type: Grant
    Filed: October 1, 2002
    Date of Patent: January 13, 2004
    Assignee: Arakis, Ltd.
    Inventors: Hazel Judith Bardsley, Robin Mark Bannister, Julian Clive Gilbert
  • Corticosteroid formulation
    Patent number: 6488960
    Abstract: The present invention pertains to a unit dose formulation comprising 0.25 to 2 mg of a corticosteroid. This small dose can be used to treat rheumatoid arthritis, especially if adapted to release at least 90% by weight of the corticosteroid, 2 to 8 hours after administration.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: December 3, 2002
    Assignee: Arakis Ltd.
    Inventor: Hazel Judith Bardsley